Korea vs Mexico: Avoidable mortality
Avoidable mortality over time
- Korea
- Mexico
How they compare
Mexico currently reports 373,220 Deaths against 85,016 Deaths in Korea, a difference of 288,204 Deaths.
That makes Mexico's figure about 4.4 times Korea's.
Across all 24 years both countries report, Mexico has been ahead every year.
Korea ranks 1st and Mexico ranks 3rd of 3 groups.
Mexico has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Korea | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 113,109 Deaths | 251,650 Deaths | 138,541 Deaths | Mexico |
| 2010s | 90,899 Deaths | 310,586 Deaths | 219,687 Deaths | Mexico |
| 2020s | 85,142 Deaths | 493,299 Deaths | 408,157 Deaths | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher avoidable mortality, Korea or Mexico?
- Mexico, at 373,220 Deaths against 85,016 Deaths in Korea as of 2023.
- What is the difference in avoidable mortality between Korea and Mexico?
- 288,204 Deaths, with Mexico ahead.
- How many years of comparable data are there for Korea and Mexico?
- 24 years are reported by both, from 2000 to 2023.
- How do Korea and Mexico rank globally for avoidable mortality?
- Korea ranks 1st and Mexico ranks 3rd of 3 groups.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Avoidable mortality. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents data on preventable, treatable and avoidable (preventable + treatable) causes of mortality. Preventable and treatable causes of mortality are defined as follows: - Preventable mortality: Causes of death that can be mainly avoided through effective public health and primary prevention interventions (i.e. before the onset of diseases/injuries, to reduce incidence). - Treatable (or amenable) mortality: Causes of death that can be mainly avoided through timely and effective healthcare interventions, including secondary prevention such as screening, and treatment (i.e. after the onset of diseases, to reduce case-fatality). Both indicators refer to premature mortality (under age 75). Please refer to the Sources and Methods for detailed country-specific information.